[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
April 14, 1997

The Costs of Lyme Disease-Reply

Author Affiliations

New Brunswick, NJ

Arch Intern Med. 1997;157(7):817-818. doi:10.1001/archinte.1997.00440280167017

McCaulley makes an important point: in many practices, even those based in and near areas endemic for Lyme disease, that diagnosis is often missed and may not even be considered. This concept, which has been dealt with in a previous article,1 was one of the major points made at the National Clinical Conference on Lyme Disease2 and, in fact, is one of the goals of the extant, broad, clinical literature on Lyme disease. However, in clinical practice in endemic and near-to-endemic areas, a larger problem is overdiagnosis and overtreatment.3-5

It is critical that the diagnosis of Lyme disease be considered when appropriate, a point made in the article under discussion3 and in previous discussions of overdiagnosis.1 Lyme disease should be included within the differential diagnosis when prudent clinical practice suggests that it is a plausible explanation of the patient's problems. However, the diagnosis should not

First Page Preview View Large
First page PDF preview
First page PDF preview